Knowledge

Proxymetacaine

Source 📝

395: 372: 29: 620:
Proxymetacaine is for topical ophthalmic use only, and it is specifically not intended for injection. Prolonged use of this or any other topical ocular anesthetic may produce permanent
636:
Proxymetacaine is available as its hydrochloride salt in ophthalmic solutions at a concentration of 0.5%. Although it is no longer on patent, it is still marketed under the
669: 664:[Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). 580:
to affect the permeability of neuronal membranes; how this inhibits pain sensations and the exact mechanism of action of proxymetacaine are, however, unknown.
78: 123: 41: 478: 754:
Murphy PJ, Ntola AM (April 2009). "Prolonged corneal anaesthesia by proxymetacaine hydrochloride detected by a thermal cooling stimulus".
1028: 832: 464: 1159: 1125: 1218: 661: 564:
Proxymetacaine is a local anesthetic which on topical application penetrates sensory nerve endings in the corneal tissue.
523: 738: 657: 537: 498: 1176: 1228: 825: 160: 108: 810: 240: 1034: 662:"RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" 665: 390: 291: 506:
InChI=1S/C16H26N2O3/c1-4-10-20-15-8-7-13(12-14(15)17)16(19)21-11-9-18(5-2)6-3/h7-8,12H,4-6,9-11,17H2,1-3H3
351: 1203: 818: 545: 340: 191: 367: 1208: 1164: 640:
Alcaine, Ak-Taine, and others. Proparacaine 0.5% is marketed as Poencaina by Poen Laboratories.
59: 1223: 846: 1130: 621: 231: 1135: 300: 280: 51: 8: 871: 573: 186: 177: 394: 371: 549: 1213: 771: 734: 727: 707: 841: 763: 699: 407: 134: 91: 1065: 987: 924: 919: 690:
Draeger J, Langenbucher H, Bannert C (1984). "Efficacy of topical anaesthetics".
220: 142: 852: 840: 1170: 899: 767: 577: 20: 1197: 1074: 992: 383: 195: 790:"Poen-Caina generic. Price of poen-caina. Uses, Indications and Description" 969: 939: 904: 775: 601: 553: 86: 28: 711: 1140: 1099: 1084: 1069: 1061: 1012: 914: 884: 625: 609: 260: 1145: 1109: 1104: 1089: 1007: 1002: 977: 959: 934: 929: 879: 789: 637: 597: 440: 271: 703: 1094: 1079: 1056: 954: 889: 593: 206: 45: 944: 894: 589: 320: 251: 70: 604:, or other similar procedures requiring topical anesthesia of the 463: 997: 982: 909: 66: 605: 331: 1048: 861: 454: 356: 311: 689: 724: 239: 726: 588:Proxymetacaine hydrochloride ophthalmic solution ( 1195: 219: 185: 168:2-(diethylamino)ethyl 3-amino-4-propoxybenzoate 826: 753: 833: 819: 393: 370: 279: 27: 733:(6th ed.). New York: MacMillan Pub. 729:The Pharmacological Basis of Therapeutics 725:Goodman LS, Gilman AG, Goodman A (1980). 299: 583: 572:Proxymetacaine is believed to act as an 559: 366: 259: 1196: 656: 592:) is indicated for procedures such as 567: 384: 814: 339: 50: 90: 319: 210: 13: 14: 1240: 486:O=C(OCCN(CC)CC)c1ccc(OCCC)c(c1)N 424: 418: 756:Contact Lens & Anterior Eye 672:from the original on 2023-08-03 631: 511:Key:KCLANYCVBBTKTO-UHFFFAOYSA-N 782: 747: 718: 683: 650: 430: 412: 117: 1: 1035:3-(p-Fluorobenzoyloxy)tropane 1022:ArCO2- (not para-amino or Ph) 643: 126:(Other controlled substances) 7: 1219:Drugs developed by Novartis 615: 10: 1245: 1126:Anesthetic/vasoconstrictor 768:10.1016/j.clae.2008.12.006 402:Chemical and physical data 1154: 1118: 1047: 1031:(3,4,5-Trimethoxybenzoyl) 1021: 968: 870: 860: 519: 494: 474: 452: 439: 406: 401: 382: 350: 330: 310: 290: 270: 250: 230: 205: 176: 156: 151: 141: 133: 107: 102: 77: 58: 40: 35: 26: 762:(2): 84–7, quiz 99–100. 668:(published 2023-04-04). 52:International Drug Names 1085:Cinchocaine (Dibucaine) 847:sodium channel blockers 666:Diário Oficial da União 1229:Diethylamino compounds 1131:Bupivacaine/meloxicam 622:corneal opacification 584:Indications and usage 560:Clinical pharmacology 1136:Lidocaine/prilocaine 945:Procaine (Novocaine) 692:Ophthalmic Research 568:Mechanism of action 23: 1181:Never to phase III 624:with accompanying 550:topical anesthetic 19: 1204:Local anesthetics 1191: 1190: 1043: 1042: 842:Local anesthetics 704:10.1159/000265308 576:on voltage-gated 531: 530: 465:Interactive image 352:CompTox Dashboard 121: 16:Chemical compound 1236: 868: 867: 850: 835: 828: 821: 812: 811: 805: 804: 802: 800: 786: 780: 779: 751: 745: 744: 732: 722: 716: 715: 687: 681: 680: 678: 677: 654: 527: 526: 467: 447: 432: 426: 420: 414: 397: 386: 375: 374: 360: 358: 343: 323: 303: 283: 263: 243: 223: 213: 212: 189: 119: 116: 94: 54: 31: 24: 22: 18: 1244: 1243: 1239: 1238: 1237: 1235: 1234: 1233: 1209:Benzoate esters 1194: 1193: 1192: 1187: 1186: 1171:Clinical trials 1150: 1114: 1066:Levobupivacaine 1039: 1017: 988:Cyclomethycaine 964: 925:Metabutoxycaine 920:Metabutethamine 856: 844: 839: 809: 808: 798: 796: 788: 787: 783: 752: 748: 741: 723: 719: 688: 684: 675: 673: 655: 651: 646: 634: 618: 586: 578:sodium channels 570: 562: 522: 520: 515: 512: 507: 502: 501: 490: 487: 482: 481: 470: 445: 435: 429: 423: 417: 378: 354: 346: 326: 306: 286: 266: 246: 226: 209: 201: 190: 172: 169: 164: 163: 135:Pharmacokinetic 129: 98: 61: 17: 12: 11: 5: 1242: 1232: 1231: 1226: 1221: 1216: 1211: 1206: 1189: 1188: 1185: 1184: 1183: 1182: 1179: 1168: 1162: 1156: 1155: 1152: 1151: 1149: 1148: 1143: 1138: 1133: 1128: 1122: 1120: 1116: 1115: 1113: 1112: 1107: 1102: 1097: 1092: 1087: 1082: 1077: 1072: 1059: 1053: 1051: 1045: 1044: 1041: 1040: 1038: 1037: 1032: 1025: 1023: 1019: 1018: 1016: 1015: 1010: 1005: 1000: 995: 990: 985: 980: 974: 972: 966: 965: 963: 962: 957: 952: 950:Proxymetacaine 947: 942: 937: 932: 927: 922: 917: 912: 907: 902: 900:Chloroprocaine 897: 892: 887: 882: 876: 874: 865: 858: 857: 838: 837: 830: 823: 815: 807: 806: 781: 746: 740:978-0023447204 739: 717: 682: 660:(2023-03-31). 648: 647: 645: 642: 633: 630: 617: 614: 602:foreign bodies 585: 582: 569: 566: 561: 558: 534:Proxymetacaine 529: 528: 517: 516: 514: 513: 510: 508: 505: 497: 496: 495: 492: 491: 489: 488: 485: 477: 476: 475: 472: 471: 469: 468: 460: 458: 450: 449: 443: 437: 436: 433: 427: 421: 415: 410: 404: 403: 399: 398: 388: 380: 379: 377: 376: 368:DTXSID30198146 363: 361: 348: 347: 345: 344: 336: 334: 328: 327: 325: 324: 316: 314: 308: 307: 305: 304: 296: 294: 288: 287: 285: 284: 276: 274: 268: 267: 265: 264: 256: 254: 248: 247: 245: 244: 236: 234: 228: 227: 225: 224: 216: 214: 203: 202: 200: 199: 182: 180: 174: 173: 171: 170: 167: 159: 158: 157: 154: 153: 149: 148: 145: 139: 138: 131: 130: 128: 127: 113: 111: 105: 104: 100: 99: 97: 96: 83: 81: 75: 74: 64: 62:administration 56: 55: 48: 38: 37: 33: 32: 21:Proxymetacaine 15: 9: 6: 4: 3: 2: 1241: 1230: 1227: 1225: 1224:Phenol ethers 1222: 1220: 1217: 1215: 1212: 1210: 1207: 1205: 1202: 1201: 1199: 1180: 1178: 1175: 1174: 1172: 1169: 1166: 1163: 1161: 1158: 1157: 1153: 1147: 1144: 1142: 1139: 1137: 1134: 1132: 1129: 1127: 1124: 1123: 1121: 1117: 1111: 1108: 1106: 1103: 1101: 1098: 1096: 1093: 1091: 1088: 1086: 1083: 1081: 1078: 1076: 1075:Butanilicaine 1073: 1071: 1067: 1063: 1060: 1058: 1055: 1054: 1052: 1050: 1046: 1036: 1033: 1030: 1027: 1026: 1024: 1020: 1014: 1011: 1009: 1006: 1004: 1001: 999: 996: 994: 991: 989: 986: 984: 981: 979: 976: 975: 973: 971: 967: 961: 958: 956: 953: 951: 948: 946: 943: 941: 938: 936: 933: 931: 928: 926: 923: 921: 918: 916: 913: 911: 908: 906: 903: 901: 898: 896: 893: 891: 888: 886: 883: 881: 878: 877: 875: 873: 869: 866: 863: 859: 854: 848: 843: 836: 831: 829: 824: 822: 817: 816: 813: 795: 791: 785: 777: 773: 769: 765: 761: 757: 750: 742: 736: 731: 730: 721: 713: 709: 705: 701: 697: 693: 686: 671: 667: 663: 659: 653: 649: 641: 639: 629: 627: 623: 613: 611: 607: 603: 600:, removal of 599: 595: 591: 581: 579: 575: 565: 557: 555: 551: 547: 543: 539: 535: 525: 518: 509: 504: 503: 500: 493: 484: 483: 480: 473: 466: 462: 461: 459: 456: 451: 444: 442: 438: 411: 409: 405: 400: 396: 392: 389: 387: 385:ECHA InfoCard 381: 373: 369: 365: 364: 362: 353: 349: 342: 338: 337: 335: 333: 329: 322: 318: 317: 315: 313: 309: 302: 298: 297: 295: 293: 289: 282: 278: 277: 275: 273: 269: 262: 258: 257: 255: 253: 249: 242: 238: 237: 235: 233: 229: 222: 218: 217: 215: 208: 204: 197: 193: 188: 184: 183: 181: 179: 175: 166: 165: 162: 155: 150: 146: 144: 140: 136: 132: 125: 115: 114: 112: 110: 106: 101: 93: 88: 85: 84: 82: 80: 76: 72: 68: 65: 63: 57: 53: 49: 47: 43: 39: 36:Clinical data 34: 30: 25: 1119:Combinations 949: 940:Propoxycaine 905:Dimethocaine 872:Aminobenzoic 797:. Retrieved 793: 784: 759: 755: 749: 728: 720: 698:(3): 135–8. 695: 691: 685: 674:. Retrieved 652: 635: 632:How supplied 619: 587: 571: 563: 552:drug of the 542:proparacaine 541: 533: 532: 521:   109:Legal status 103:Legal status 1167:from market 1100:Mepivacaine 1070:Ropivacaine 1062:Bupivacaine 1013:Piperocaine 915:Meprylcaine 885:Benzonatate 845:(primarily 638:trade names 626:visual loss 610:conjunctiva 448: g·mol 391:100.007.169 152:Identifiers 1198:Categories 1146:Iontocaine 1110:Trimecaine 1105:Prilocaine 1090:Etidocaine 1080:Carticaine 1008:Isobucaine 1003:Hexylcaine 978:Amylocaine 960:Tetracaine 935:Orthocaine 930:Nitracaine 880:Benzocaine 676:2023-08-16 644:References 598:gonioscopy 574:antagonist 554:aminoester 453:3D model ( 441:Molar mass 341:ChEMBL1196 301:B4OB0JHI1X 272:ChemSpider 232:IUPHAR/BPS 178:CAS Number 161:IUPAC name 143:Metabolism 1177:Phase III 1165:Withdrawn 1095:Lidocaine 1057:Articaine 1029:Amoproxan 998:β-Eucaine 993:α-Eucaine 955:Risocaine 890:Butacaine 594:tonometry 590:eye drops 192:5875-06-9 71:eye drops 60:Routes of 46:Drugs.com 1214:Anilines 895:Butamben 799:15 March 776:19181566 670:Archived 616:Warnings 524:(verify) 252:DrugBank 187:499-67-2 124:Class C1 79:ATC code 983:Cocaine 970:Benzoic 910:Lucaine 864:by acid 712:6472792 556:group. 548:) is a 446:294.395 408:Formula 261:DB00807 207:PubChem 95:) 89: ( 87:S01HA04 67:Topical 1160:WHO-EM 1049:Amides 862:Esters 794:ndrugs 774:  737:  710:  658:Anvisa 606:cornea 479:SMILES 332:ChEMBL 321:D08448 147:Plasma 122: 540:) or 499:InChI 455:JSmol 853:N01B 801:2018 772:PMID 735:ISBN 708:PMID 608:and 546:USAN 312:KEGG 292:UNII 281:4766 241:7283 221:4935 137:data 42:AHFS 1141:TAC 764:doi 700:doi 538:INN 357:EPA 211:CID 196:HCl 92:WHO 1200:: 1173:: 792:. 770:. 760:32 758:. 706:. 696:16 694:. 628:. 612:. 596:, 422:26 416:16 118:BR 1068:/ 1064:/ 855:) 851:( 849:) 834:e 827:t 820:v 803:. 778:. 766:: 743:. 714:. 702:: 679:. 544:( 536:( 457:) 434:3 431:O 428:2 425:N 419:H 413:C 359:) 355:( 198:) 194:( 120:: 73:) 69:( 44:/

Index


AHFS
Drugs.com
International Drug Names
Routes of
administration

Topical
eye drops
ATC code
S01HA04
WHO
Legal status
Class C1
Pharmacokinetic
Metabolism
IUPAC name
CAS Number
499-67-2
5875-06-9
HCl
PubChem
4935
IUPHAR/BPS
7283
DrugBank
DB00807
ChemSpider
4766
UNII
B4OB0JHI1X
KEGG

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.